Annexin Pharmaceuticals AB (publ) (STO: ANNX)
0.530
-0.024 (-4.33%)
Sep 2, 2024, 11:26 AM CET
ANNX Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 21.15 | 19.14 | 26.34 | 18.07 | 1.29 | 6.38 | Upgrade
|
Cash & Short-Term Investments | 21.15 | 19.14 | 26.34 | 18.07 | 1.29 | 6.38 | Upgrade
|
Cash Growth | 7.26% | -27.32% | 45.79% | 1302.56% | -79.82% | -68.00% | Upgrade
|
Accounts Receivable | 11.74 | 10.32 | 3.67 | 3.51 | 9.99 | 3.25 | Upgrade
|
Other Receivables | - | 1.23 | 2.92 | 1.14 | 2.67 | 2.71 | Upgrade
|
Receivables | 11.74 | 11.55 | 6.6 | 4.65 | 12.66 | 5.96 | Upgrade
|
Prepaid Expenses | - | 2.08 | 1.79 | 6.09 | 1.92 | 0.71 | Upgrade
|
Other Current Assets | - | -0 | -0 | - | - | - | Upgrade
|
Total Current Assets | 32.89 | 32.77 | 34.72 | 28.81 | 15.88 | 13.05 | Upgrade
|
Property, Plant & Equipment | 0.36 | 0.5 | 0.79 | 1.08 | 1.37 | 0.01 | Upgrade
|
Long-Term Investments | - | - | 0.09 | - | - | - | Upgrade
|
Other Intangible Assets | 18.51 | 0.44 | 0.54 | 0.64 | 0.73 | 0.83 | Upgrade
|
Long-Term Deferred Charges | - | 17.37 | 15.53 | 11.95 | 9.36 | 7.72 | Upgrade
|
Other Long-Term Assets | - | 0 | - | 1.35 | 1.23 | 1.36 | Upgrade
|
Total Assets | 51.76 | 51.07 | 51.66 | 43.82 | 28.57 | 22.98 | Upgrade
|
Accounts Payable | - | 2.21 | 2.47 | 1.84 | 2.69 | 1.3 | Upgrade
|
Accrued Expenses | - | 4.58 | 4.33 | 6.94 | 6.01 | 3.83 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | 0.86 | 0.86 | 0.86 | Upgrade
|
Current Unearned Revenue | - | 15.12 | 9.34 | 8.44 | 8.52 | 3.18 | Upgrade
|
Other Current Liabilities | 24.45 | 1.5 | 1.5 | 1.21 | 0.88 | 0.7 | Upgrade
|
Total Current Liabilities | 24.45 | 23.41 | 17.64 | 19.27 | 18.96 | 9.86 | Upgrade
|
Long-Term Debt | - | - | - | - | 0.86 | 1.71 | Upgrade
|
Other Long-Term Liabilities | 0 | -0 | -0 | - | - | - | Upgrade
|
Total Liabilities | 24.45 | 23.41 | 17.63 | 19.27 | 19.82 | 11.58 | Upgrade
|
Common Stock | 3.13 | 3.13 | 3.13 | 2.41 | 2.04 | 1.86 | Upgrade
|
Additional Paid-In Capital | 189.09 | 188.86 | 188.77 | 163.03 | 124.28 | 101.59 | Upgrade
|
Retained Earnings | -164.9 | 17.37 | 15.53 | 11.95 | 8.74 | 6.92 | Upgrade
|
Comprensive Income & Other | - | -181.69 | -173.41 | -152.83 | -126.3 | -98.96 | Upgrade
|
Total Common Equity | 27.31 | 27.67 | 34.03 | 24.55 | 8.76 | 11.4 | Upgrade
|
Shareholders' Equity | 27.31 | 27.67 | 34.03 | 24.55 | 8.76 | 11.4 | Upgrade
|
Total Liabilities & Equity | 51.76 | 51.07 | 51.66 | 43.82 | 28.57 | 22.98 | Upgrade
|
Total Debt | - | - | - | 0.86 | 1.71 | 2.57 | Upgrade
|
Net Cash (Debt) | 21.15 | 19.14 | 26.34 | 17.21 | -0.43 | 3.81 | Upgrade
|
Net Cash Growth | 7.26% | -27.32% | 53.05% | - | - | -77.51% | Upgrade
|
Net Cash Per Share | 0.54 | 0.47 | 0.76 | 0.62 | -0.02 | 0.16 | Upgrade
|
Filing Date Shares Outstanding | 39.15 | 39.15 | 39.15 | 30.11 | 25.51 | 23.19 | Upgrade
|
Total Common Shares Outstanding | 39.15 | 39.15 | 39.15 | 30.11 | 25.51 | 23.19 | Upgrade
|
Working Capital | 8.44 | 9.36 | 17.08 | 9.53 | -3.09 | 3.19 | Upgrade
|
Book Value Per Share | 0.70 | 0.71 | 0.87 | 0.82 | 0.34 | 0.49 | Upgrade
|
Tangible Book Value | 8.8 | 27.23 | 33.49 | 23.92 | 8.02 | 10.57 | Upgrade
|
Tangible Book Value Per Share | 0.22 | 0.70 | 0.86 | 0.79 | 0.31 | 0.46 | Upgrade
|
Machinery | - | 1.65 | 1.65 | 1.66 | 1.66 | 0.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.